Works matching AU Lin, Lizhu

Results: 70

Analysis of Molecular Mechanism of YiqiChutan Formula Regulating DLL4-Notch Signaling to Inhibit Angiogenesis in Lung Cancer.

Published in:

BioMed Research International, 2021, p. 1, doi. 10.1155/2021/8875503

By:

Li, Jiayin;
Han, Rui;
Li, Jing;
Zhai, Linzhu;
Xie, Xinying;
Zhang, Jing;
Chen, Yao;
Luo, Jiamin;
Wang, Sisi;
Sun, Zhe;
Cao, Yang;
Lin, Lizhu;
Yang, Qiuye

Publication type:

Article

Immortal Time Bias-Corrected Effectiveness of Traditional Chinese Medicine in Non-Small Cell Lung Cancer (C-EVID): A Prospective Cohort Study.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.845613

By:

Zhang, Xing;
Guo, Qiujun;
Li, Conghuang;
Liu, Rui;
Xu, Tao;
Jin, Zhichao;
Xi, Yupeng;
Qin, Yinggang;
Li, Weidong;
Chen, Shuntai;
Xu, Ling;
Lin, Lizhu;
Shao, Kang;
Wang, Shenyu;
Xie, Ying;
Sun, Hong;
Li, Ping;
Chu, Xiangyang;
Chai, Kequn;
Shu, Qijin

Publication type:

Article

SNAP25-induced MYC upregulation promotes highgrade neuroendocrine lung carcinoma progression.

Published in:

Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1411114

By:

Zhiqiang Chen;
Shujing Wang;
Jingrui Wang;
Ying Wang;
Xiangjun Qi;
Bo An;
Lingling Sun;
Lizhu Lin

Publication type:

Article

SNAP25-induced MYC upregulation promotes high-grade neuroendocrine lung carcinoma progression.

Published in:

Frontiers in Immunology, 2024, p. 01, doi. 10.3389/fimmu.2024.1411114

By:

Zhiqiang Chen;
Shujing Wang;
Jingrui Wang;
Ying Wang;
Xiangjun Qi;
Bo An;
Lingling Sun;
Lizhu Lin

Publication type:

Article

SNAP25-induced MYC upregulation promotes high-grade neuroendocrine lung carcinoma progression.

Published in:

Frontiers in Immunology, 2024, p. 01, doi. 10.3389/fimmu.2024.1411114

By:

Zhiqiang Chen;
Shujing Wang;
Jingrui Wang;
Ying Wang;
Xiangjun Qi;
Bo An;
Lingling Sun;
Lizhu Lin

Publication type:

Article

Sophora flavescens Containing-QYJD Formula Activates Nrf2 Anti-Oxidant Response, Blocks Cellular Transformation and Protects Against DSS-Induced Colitis in Mouse Model.

Published in:

American Journal of Chinese Medicine, 2018, v. 46, n. 7, p. 1609, doi. 10.1142/S0192415X18500829

By:

Fang, Ruoming;
Wu, Renyi;
Zuo, Qian;
Yin, Ran;
Zhang, Chengyue;
Wang, Chao;
Guo, Yue;
Yang, Anne Yuqing;
Li, Wenji;
Lin, Lizhu;
Kong, Ah-Ng

Publication type:

Article

GutUDB: A comprehensive multiomics database for intestinal diseases.

Published in:

iMeta, 2024, v. 3, n. 3, p. 1, doi. 10.1002/imt2.195

By:

Bao, Yi;
Chen, Yaxin;
Lin, Lizhu;
Li, Jingyi;
Liu, Xinli;
Wang, Gang;
Li, Yueqi;
Lin, Yao;
Chen, Yajing;
Zhou, Lijuan;
Qi, Yawen;
Xie, Yufang;
Lin, Zhenrui;
Sun, Zhe;
Fan, Yuwen;
Jiang, Jinjing;
Zhang, Feiyu;
Chen, Hubin;
Chu, Jiemei;
Huang, Jiegang

Publication type:

Article

Prediction of the effect of Bupleurum chinensis DC. (Chaihu) on survival and its potential targets in hepatocellular carcinoma based on a prognostic model.

Published in:

BMC Complementary Medicine & Therapies, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12906-025-04848-4

By:

Li, Hanhan;
Liu, Shan;
Xiang, Shang;
Guo, Wei;
Huang, Jiayang;
Yu, Ling;
Chen, Zhuangzhong;
lin, Yuan;
Lin, Lizhu;
Chen, Hanrui

Publication type:

Article

Cypher and Enigma homolog protein are essential for cardiac development and embryonic survival.

Published in:

2015

By:

Mu, Yongxin;
Jing, Ran;
Peter, Angela K.;
Lange, Stephan;
Lin, Lizhu;
Zhang, Jianlin;
Ouyang, Kunfu;
Fang, Xi;
Veevers, Jennifer;
Zhou, Xinmin;
Evans, Sylvia M.;
Cheng, Hongqiang;
Chen, Ju

Publication type:

journal article

Posterior reversible encephalopathy syndrome associated with use of anlotinib to treat squamous cell carcinoma of the cervix: case report and literature review.

Published in:

Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1255785

By:

Jietao Lin;
Wenmin Chen;
Sha Zhong;
Kai Qian;
Hanrui Chen;
Lizhu Lin

Publication type:

Article

ETS1 loss in mice impairs cardiac outflow tract septation via a cell migration defect autonomous to the neural crest.

Published in:

Human Molecular Genetics, 2022, v. 31, n. 24, p. 4217, doi. 10.1093/hmg/ddac174

By:

Lin, Lizhu;
Pinto, Antonella;
Wang, Lu;
Fukatsu, Kazumi;
Yin, Yan;
Bamforth, Simon D;
Bronner, Marianne E;
Evans, Sylvia M;
Nie, Shuyi;
Anderson, Robert H;
Terskikh, Alexey V;
Grossfeld, Paul D

Publication type:

Article

Management of small cell lung cancer complicated with paraneoplastic Cushing’s syndrome: a systematic literature review.

Published in:

Frontiers in Endocrinology, 2023, p. 1, doi. 10.3389/fendo.2023.1177125

By:

Yanlong Li;
Caiyu Li;
Xiangjun Qi;
Ling Yu;
Lizhu Lin

Publication type:

Article

Development and External Validation of a Nomogram to Predict Cancer-Specific Survival in Patients with Primary Intestinal Non-Hodgkin Lymphomas.

Published in:

Cancer Management & Research, 2021, v. 13, p. 9271, doi. 10.2147/CMAR.S339907

By:

Zhang, Cuifen;
Liu, Zeyu;
Tao, Jiahao;
Lin, Lizhu;
Zhai, Linzhu

Publication type:

Article

The impact of surgery on long-term survival of patients with primary intestinal non-Hodgkin lymphomas based on SEER database.

Published in:

Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-02597-1

By:

Zhang, Cuifen;
Zhang, Xiaohong;
Liu, Zeyu;
Tao, Jiahao;
Lin, Lizhu;
Zhai, Linzhu

Publication type:

Article

Astragalus polysaccharide (APS) attenuated PD-L1-mediated immunosuppression via the miR-133a-3p/MSN axis in HCC.

Published in:

Pharmaceutical Biology, 2022, v. 60, n. 1, p. 1710, doi. 10.1080/13880209.2022.2112963

By:

Lihua He;
Kecheng Xu;
Lizhi Niu;
Lizhu Lin

Publication type:

Article

First-line treatments for patients with advanced ALK gene rearrangements in NSCLC: a systematic review and network meta-analysis.

Published in:

Journal of International Medical Research, 2022, v. 50, n. 11, p. 1, doi. 10.1177/03000605221132703

By:

Tao, Jiahao;
Zheng, Chuangjie;
Zhang, Cuifen;
Zhou, Ling;
Liu, Zeyu;
Zhou, Yanqun;
Huang, Xuewu;
Lin, Lizhu;
Zhai, Linzhu

Publication type:

Article

Risk factors for sarcopenia in patients with head and neck cancer.

Published in:

Head & Neck, 2024, v. 46, n. 2, p. 346, doi. 10.1002/hed.27585

By:

Liu, Chen;
Cheng, Ling;
Ye, Wenfeng;
Lin, Lizhu

Publication type:

Article

Upregulated expression of NOP2 predicts worse prognosis of gastric adenocarcinoma by promoting tumor growth.

Published in:

Saudi Journal of Gastroenterology, 2022, v. 28, n. 5, p. 369, doi. 10.4103/sjg.sjg_573_21

By:

Feng, Jingyu;
Zhang, Jing;
Li, Yang;
Wang, Jiguo;
Mo, Panyan;
Lin, Lizhu

Publication type:

Article

Modulation of morphogenesis by noncanonical Wnt signaling requires ATF/CREB family–mediated transcriptional activation of TGFβ2.

Published in:

Nature Genetics, 2007, v. 39, n. 10, p. 1225, doi. 10.1038/ng2112

By:

Wenlai Zhou;
Lizhu Lin;
Majumdar, Arindam;
Xue Li;
Xiaoxue Zhang;
Wei Liu;
Etheridge, Leah;
Yunqing Shi;
Martin, James;
Van de Ven, Wim;
Kaartinen, Vesa;
Wynshaw-Boris, Anthony;
McMahon, Andrew P.;
Rosenfeld, Michael G.;
Evans, Sylvia M.

Publication type:

Article

Lactobacillus gasseri LGV03-derived indole-3-lactic acid ameliorates immune response by activating aryl hydrocarbon receptor.

Published in:

Microbial Cell Factories, 2025, v. 24, n. 1, p. 1, doi. 10.1186/s12934-025-02662-8

By:

Zhang, Zikang;
Zheng, Kangdi;
Zhang, Zhao;
Cao, Longbin;
Lin, Lizhu;
Sun, Weimin;
Qiu, Feng

Publication type:

Article

Lung abscess secondary to lung cancer with Eikenella corrodens and Streptococcus anginosus: a case report.

Published in:

2020

By:

Hu, Leihao;
Lin, Jietao;
Li, Jing;
Cao, Yang;
Lin, Lizhu

Publication type:

journal article

Construction of a Novel Lung Adenocarcinoma Immune-Related lncRNA Pair Signature.

Published in:

International Journal of General Medicine, 2021, v. 14, p. 4279, doi. 10.2147/IJGM.S325240

By:

Qi, Xiangjun;
Chen, Guoming;
Chen, Zhuangzhong;
Li, Jing;
Chen, Wenmin;
Lin, Jietao;
Lin, Lizhu

Publication type:

Article

Yiqi Chutan Tang Reduces Gefitinib‐Induced Drug Resistance in Non‐Small‐Cell Lung Cancer by Targeting Apoptosis and Autophagy.

Published in:

Cytometry. Part A, 2020, v. 97, n. 1, p. 70, doi. 10.1002/cyto.a.23869

By:

Zhang, Jue;
Sun, Lingling;
Cui, Jian;
Wang, Jing;
Liu, Xiaomin;
Aung, Thazin Nwe;
Qu, Zhipeng;
Chen, Zhuangzhong;
Adelson, David L.;
Lin, Lizhu

Publication type:

Article

Chinese multidisciplinary expert consensus on the management of adverse drug reactions associated with savolitinib.

Published in:

Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231216089

By:

Zhang, Li;
Wang, Yongsheng;
Lin, Lizhu;
Yu, Yongfeng;
Lu, Shun

Publication type:

Article

Shenqi Fuzheng injection facilitates skeletal muscle mitophagy mediated by the ubiquitination of HIF‐1α to ameliorate cancer‐associated fatigue.

Published in:

Journal of Cellular & Molecular Medicine, 2024, v. 28, n. 12, p. 1, doi. 10.1111/jcmm.18455

By:

Guo, Wei;
Liu, Shan;
Xia, Huan;
Luo, Jiamin;
Chen, Hanrui;
Hu, Leihao;
Zheng, Xinting;
Xiao, Zhiwei;
Lin, Lizhu

Publication type:

Article

Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance.

Published in:

NPJ Precision Oncology, 2024, v. 8, p. 1, doi. 10.1038/s41698-024-00522-z

By:

Wang, Shujing;
Wang, Jingrui;
Chen, Zhiqiang;
Luo, Jiamin;
Guo, Wei;
Sun, Lingling;
Lin, Lizhu

Publication type:

Article

Tiliroside as a CAXII inhibitor suppresses liver cancer development and modulates E2Fs/Caspase-3 axis.

Published in:

Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-88133-7

By:

Han, Rui;
Yang, Hongxing;
Lu, Lingeng;
Lin, Lizhu

Publication type:

Article

The Biological Mechanisms and Clinical Roles of RNA-Binding Proteins in Cardiovascular Diseases.

Published in:

Biomolecules (2218-273X), 2024, v. 14, n. 9, p. 1056, doi. 10.3390/biom14091056

By:

Lin, Lizhu;
Chu, Jiemei;
An, Sanqi;
Liu, Xinli;
Tan, Runxian

Publication type:

Article

Expert Consensus on Prevention and Treatment of COVID-19 Infection in Patients with Lung Cancer.

Published in:

Chinese Journal of Lung Cancer, 2023, v. 26, n. 3, p. 165, doi. 10.3779/j.issn.1009-3419.2023.102.12

By:

Jinming YU;
Jie WANG;
Hongzhou LU;
Ligang XING;
Weimin LI;
Junling LI;
Nong YANG;
Jianxing HE;
Yong SONG;
Li ZHANG;
Lizhu LIN;
Min ZHOU;
Caicun ZHOU;
Qinghua ZHOU;
Hua ZHONG;
Shuanghu YUAN

Publication type:

Article

Exploring the mechanism of aidi injection for lung cancer by network pharmacology approach and molecular docking validation.

Published in:

Bioscience Reports, 2021, v. 41, n. 2, p. 1, doi. 10.1042/BSR20204062

By:

Zhenjie Zhuang;
Tong Lin;
Lixia Luo;
Weixin Zhou;
Junmao Wen;
Haifu Huang;
Zhanhua Liu;
Lizhu Lin

Publication type:

Article

The characteristics of ctDNA reveal the high complexity in matching the corresponding tumor tissues.

Published in:

2018

By:

Nong Yang;
Yi Li;
Zhidong Liu;
Hao Qin;
Duanming Du;
Xinkai Cao;
Xiaoqing Cao;
Jun Li;
Dongge Li;
Bo Jiang;
Lincan Duan;
Haiyan Yang;
Zhenghua Zhang;
Hao Lin;
Jianying Li;
Zhenhua Yang;
Lei Xiong;
Lizhu Lin;
Hua Shen;
Fugen Li

Publication type:

journal article

Differentiation and treatment of lung cancer with cardiovascular diseasecomorbidity.

Published in:

Journal of Beijing University of Traditional Chinese Medicine, 2025, v. 48, n. 6, p. 1, doi. 10.3969/j.issn.1006-2157.2025.06.015

By:

Lingling, SUN;
Yiying, LYU;
Duo, LI;
Yinshuang, LIU;
Lizhu, LIN

Publication type:

Article

Case Report: Clinical benefit from multi-target tyrosine kinase inhibitor and PARP inhibitor in a patient with cancer of unknown primary with BRCA1 large genomic rearrangement.

Published in:

Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.997760

By:

Ling Yu;
Jietao Lin;
Hanhan Li;
Lingling Sun;
Shubo Wang;
Yaoxu Chen;
Hanrui Chen;
Lizhu Lin

Publication type:

Article

Research Trend of Publications Concerning Antibody-Drug Conjugate in Solid Cancer: A Bibliometric Study.

Published in:

Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.921385

By:

Qi, Xiangjun;
Li, Yanlong;
Liu, Wei;
Wang, Yifan;
Chen, Zhuangzhong;
Lin, Lizhu

Publication type:

Article

Deciphering the Effects and Mechanisms of Yi-Fei-San-Jie-pill on Non-Small Cell Lung Cancer With Integrating Network Target Analysis and Experimental Validation.

Published in:

Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.851554

By:

Yang, Hongxing;
Guo, Qiuyan;
Wu, Jianbin;
Zhong, Lixia;
Sun, Lingling;
Liu, Wei;
Wang, Jigang;
Lin, Lizhu

Publication type:

Article

Anoikis-Associated Lung Cancer Metastasis: Mechanisms and Therapies.

Published in:

Cancers, 2022, v. 14, n. 19, p. 4791, doi. 10.3390/cancers14194791

By:

Wang, Jing;
Luo, Zhijie;
Lin, Lizhu;
Sui, Xinbing;
Yu, Lili;
Xu, Cong;
Zhang, Ruonan;
Zhao, Ziming;
Zhu, Qianru;
An, Bo;
Wang, Qiao;
Chen, Bi;
Leung, Elaine Lai-Han;
Wu, Qibiao

Publication type:

Article

Linear-like polypeptide-based micelle with pH-sensitive detachable PEG to deliver dimeric camptothecin for cancer therapy.

Published in:

Asian Journal of Pharmaceutical Sciences, 2023, v. 18, n. 1, p. 1, doi. 10.1016/j.ajps.2022.100773

By:

Ka Hong Wong;
Zhaopei Guo;
Di Jiang;
Xingzhi Zhou;
Lizhu Lin;
Denggao Zhao;
Meiwan Chen

Publication type:

Article

Network pharmacology based research into the effect and mechanism of Yinchenhao Decoction against Cholangiocarcinoma.

Published in:

Chinese Medicine, 2021, v. 16, n. 1, p. 1, doi. 10.1186/s13020-021-00423-4

By:

Chen, Zhiqiang;
Lin, Tong;
Liao, Xiaozhong;
Li, Zeyun;
Lin, Ruiting;
Qi, Xiangjun;
Chen, Guoming;
Sun, Lingling;
Lin, Lizhu

Publication type:

Article

Capecitabine metronomic chemotherapy for metastatic colorectal cancer patients reaching NED: A protocol for a prospective, randomized, controlled trial.

Published in:

PLoS ONE, 2025, v. 20, n. 4, p. 1, doi. 10.1371/journal.pone.0320591

By:

Wu, Jiaming;
Dong, Yu;
Zhu, Wanshan;
Meng, Jincheng;
Zhang, Huatang;
Fang, Cantu;
Lin, Lizhu

Publication type:

Article

Efficacy and safety of Jianpishengsui for chemotherapy-related fatigue in patients with non-small cell lung cancer: study protocol for a randomized placebo-controlled clinical trial.

Published in:

2020

By:

Xiao, Zhiwei;
Hu, Leihao;
Lin, Jietao;
Lu, Liming;
Huang, Xuewu;
Zhu, Xiaoshu;
Teo, Chiahshean;
Lin, Lizhu

Publication type:

journal article

The impact of sarcopenia on the outcome of patients with left-sided colon and rectal cancer after curative surgery.

Published in:

BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11073-0

By:

Li, Qi;
An, Tailai;
Wu, Jianbin;
Lu, Weiqi;
Wang, Yan;
Li, Jia;
Yang, Lina;
Chen, Yiqi;
Lin, Lizhu;
Yang, Zhenjiang

Publication type:

Article

Functional drug-target-disease network analysis of gene-phenotype connectivity for curcumin in hepatocellular carcinoma.

Published in:

PeerJ, 2021, p. 1, doi. 10.7717/peerj.12339

By:

Yuanyuan Zhao;
Jiahao Tao;
Zhuangzhong Chen;
Suihui Li;
Zeyu Liu;
Lizhu Lin;
Linzhu Zhai

Publication type:

Article

Combination of Cordycepin and Apatinib Synergistically Inhibits NSCLC Cells by Down-Regulating VEGF/PI3K/Akt Signaling Pathway.

Published in:

Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.01732

By:

Liao, Xiaozhong;
Tao, Lanting;
Guo, Wei;
Wu, Zhuo-Xun;
Du, Haiyan;
Wang, Jing;
Zhang, Jue;
Chen, Hanrui;
Chen, Zhe-Sheng;
Lin, Lizhu;
Sun, Lingling

Publication type:

Article

Methyl-Cantharidimide (MCA) Has Anticancer Efficacy in ABCB1- and ABCG2-Overexpressing and Cisplatin Resistant Cancer Cells.

Published in:

Frontiers in Oncology, 2020, p. 1, doi. 10.3389/fonc.2020.00932

By:

Li, Yi-Dong;
Mao, Yong;
Dong, Xing-Duo;
Lei, Zi-Ning;
Yang, Yuqi;
Lin, Lizhu;
Ashby, Charles R.;
Yang, Dong-Hua;
Fan, Ying-Fang;
Chen, Zhe-Sheng

Publication type:

Article

M3814, a DNA-PK Inhibitor, Modulates ABCG2-Mediated Multidrug Resistance in Lung Cancer Cells.

Published in:

Frontiers in Oncology, 2020, v. 10, p. 1, doi. 10.3389/fonc.2020.00674

By:

Wu, Zhuo-Xun;
Peng, Zheng;
Yang, Yuqi;
Wang, Jing-Quan;
Teng, Qiu-Xu;
Lei, Zi-Ning;
Fu, Yi-Ge;
Patel, Ketankumar;
Liu, Lili;
Lin, Lizhu;
Zou, Chang;
Chen, Zhe-Sheng

Publication type:

Article

Multiplexed imaging of tumor immune microenvironmental markers in locally advanced or metastatic non‐small‐cell lung cancer characterizes the features of response to PD‐1 blockade plus chemotherapy.

Published in:

Cancer Communications, 2022, v. 42, n. 12, p. 1331, doi. 10.1002/cac2.12383

By:

Wu, Fengying;
Jiang, Tao;
Chen, Gongyan;
Huang, Yunchao;
Zhou, Jianying;
Lin, Lizhu;
Feng, Jifeng;
Wang, Zhehai;
Shu, Yongqian;
Shi, Jianhua;
Hu, Yi;
Wang, Qiming;
Cheng, Ying;
Chen, Jianhua;
Lin, Xiaoyan;
Wang, Yongsheng;
Huang, Jianan;
Cui, Jiuwei;
Cao, Lejie;
Liu, Yunpeng

Publication type:

Article

Primary Resistance to Brigatinib in a Patient with Lung Adenocarcinoma Harboring ALK G1202R Mutation and LIPI-NTRK1 Rearrangement.

Published in:

OncoTargets & Therapy, 2020, v. 13, p. 4591, doi. 10.2147/OTT.S249652

By:

Xiao, Zhiwei;
Huang, Xuewu;
Xie, Biyuan;
Xie, Wenzhuan;
Huang, Mengli;
Lin, Lizhu

Publication type:

Article

Sunitinib-and-Chinese herbal medicine-based systematic treatment clinically cured a patient with multiple metastatic primary clear cell carcinoma of the liver: a case report.

Published in:

OncoTargets & Therapy, 2019, v. 12, p. 2823, doi. 10.2147/OTT.S197923

By:

Sun, Lingling;
Chen, Hanrui;
Xiao, Zhiwei;
Guo, Wei;
Lin, Lizhu

Publication type:

Article

The dietary flavone luteolin epigenetically activates the Nrf2 pathway and blocks cell transformation in human colorectal cancer HCT116 cells.

Published in:

Journal of Cellular Biochemistry, 2018, v. 119, n. 11, p. 9573, doi. 10.1002/jcb.27275

By:

Zuo, Qian;
Wu, Renyi;
Xiao, Xi;
Yang, Caizhi;
Yang, Yuqing;
Wang, Chao;
Lin, Lizhu;
Kong, Ah‐Ng

Publication type:

Article

The dietary flavone luteolin epigenetically activates the Nrf2 pathway and blocks cell transformation in human colorectal cancer HCT116 cells.

Published in:

Journal of Cellular Biochemistry, 2018, v. 119, n. 11, p. 9573, doi. 10.1002/jcb.27275

By:

Zuo, Qian;
Wu, Renyi;
Xiao, Xi;
Yang, Caizhi;
Yang, Yuqing;
Wang, Chao;
Lin, Lizhu;
Kong, Ah‐Ng

Publication type:

Article